Sarepta Therapeutics, Inc.
NASDAQ:SRPT
124.65 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,243.336 | 933.013 | 701.887 | 540.099 | 380.833 | 301.034 | 154.584 | 5.421 | 1.253 | 9.757 | 14.219 | 37.329 | 46.99 | 29.42 | 17.585 | 21.258 | 10.985 | 0.115 | 4.784 | 0.43 | 0.97 | 0.837 | 0.706 | 1.297 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Cost of Revenue
| 150.343 | 139.989 | 97.049 | 63.382 | 56.586 | 34.193 | 7.353 | 0.13 | 146.194 | 94.103 | 90.284 | 51.933 | 35.927 | 27.458 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.416 | 0 | -0.2 | -0.5 | -0.5 | 0 |
| Gross Profit
| 1,092.993 | 793.024 | 604.838 | 476.717 | 324.247 | 266.841 | 147.231 | 5.291 | -144.941 | -84.346 | -76.065 | -14.604 | 11.063 | 1.962 | 17.585 | 21.258 | 10.985 | 0.115 | 4.784 | 0.43 | 0.97 | 0.837 | 0.706 | 1.714 | 0.1 | 0.4 | 0.6 | 0.6 | 0.1 |
| Gross Profit Ratio
| 0.879 | 0.85 | 0.862 | 0.883 | 0.851 | 0.886 | 0.952 | 0.976 | -115.675 | -8.645 | -5.35 | -0.391 | 0.235 | 0.067 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.321 | 1 | 2 | 6 | 6 | 1 |
| Reseach & Development Expenses
| 877.387 | 877.09 | 771.182 | 722.343 | 560.909 | 401.843 | 166.707 | 188.272 | 146.394 | 94.231 | 72.909 | 52.402 | 66.862 | 35.972 | 24.396 | 29.003 | 34.76 | 25.346 | 17.118 | 20.739 | 15.284 | 22.414 | 12.751 | 9.268 | 6.7 | 6.3 | 2.7 | 1.7 | 2.1 |
| General & Administrative Expenses
| 481.871 | 451.421 | 282.66 | 317.875 | 284.812 | 209.983 | 119.85 | 81.201 | 75.043 | 49.315 | 31.594 | 14.63 | 16.055 | 14.382 | 8.696 | 9.797 | 9.332 | 7.753 | 5.182 | 4.736 | 4.559 | 3.764 | 3.358 | 2.27 | 1.7 | 1.6 | 1.3 | 0.6 | 0.6 |
| Selling & Marketing Expenses
| 28.6 | 14.6 | 7.7 | 0 | 0 | -2.222 | 2.832 | 2.548 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 481.871 | 451.421 | 282.66 | 317.875 | 284.812 | 207.761 | 122.682 | 83.749 | 75.043 | 49.315 | 31.594 | 14.63 | 16.055 | 14.382 | 8.696 | 9.797 | 9.332 | 7.753 | 5.182 | 4.736 | 4.559 | 3.764 | 3.358 | 2.27 | 1.7 | 1.6 | 1.3 | 0.6 | 0.6 |
| Other Expenses
| 1.559 | 0.714 | 0.706 | 0.662 | 0.849 | -0.656 | 1.982 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.416 | 0 | 0.2 | 0.5 | 0.5 | 0 |
| Operating Expenses
| 1,360.817 | 1,329.225 | 1,054.548 | 1,040.88 | 846.57 | 610.469 | 290.442 | 272.021 | 221.437 | 143.546 | 104.503 | 67.032 | 82.917 | 50.354 | 33.092 | 38.799 | 44.093 | 33.098 | 22.3 | 25.474 | 19.843 | 26.178 | 16.109 | 11.955 | 8.4 | 8.1 | 4.5 | 2.8 | 2.7 |
| Operating Income
| -267.824 | -536.201 | -449.71 | -564.163 | -522.323 | -343.628 | -171.638 | -266.73 | -220.184 | -133.789 | -90.284 | -29.703 | -35.927 | -20.934 | -15.507 | -27.458 | -33.108 | -32.983 | -17.516 | -25.044 | -18.873 | -25.341 | -15.403 | -10.241 | -8.3 | -7.7 | -3.9 | -2.2 | -2.6 |
| Operating Income Ratio
| -0.215 | -0.575 | -0.641 | -1.045 | -1.372 | -1.141 | -1.11 | -49.203 | -175.725 | -13.712 | -6.35 | -0.796 | -0.765 | -0.712 | -0.882 | -1.292 | -3.014 | -286.085 | -3.662 | -58.179 | -19.46 | -30.284 | -21.814 | -7.894 | -83 | -38.5 | -39 | -22 | -26 |
| Total Other Income Expenses Net
| -252.274 | -153.762 | 30.762 | 11.098 | -191.557 | 10.139 | 96.573 | -2.548 | 0.154 | -2.779 | -22.027 | -91.938 | 33.022 | -11.502 | -9.198 | -6.755 | 4.956 | 1.91 | 0.84 | 0.266 | 3.766 | -4.478 | -12.523 | 1.001 | -0.1 | -19 | 0.4 | 0.2 | 0 |
| Income Before Tax
| -520.098 | -689.963 | -418.948 | -553.065 | -713.88 | -362.61 | -48.628 | -267.265 | -220.03 | -135.789 | -111.985 | -121.287 | -2.318 | -23.953 | -24.705 | -23.953 | -28.152 | -31.073 | -16.676 | -24.778 | -14.617 | -29.359 | -8.278 | -9.24 | -8.4 | -26.7 | -3.5 | -2 | -2.6 |
| Income Before Tax Ratio
| -0.418 | -0.739 | -0.597 | -1.024 | -1.875 | -1.205 | -0.315 | -49.302 | -175.603 | -13.917 | -7.876 | -3.249 | -0.049 | -0.814 | -1.405 | -1.127 | -2.563 | -269.518 | -3.486 | -57.561 | -15.071 | -35.086 | -11.724 | -7.122 | -84 | -133.5 | -35 | -20 | -26 |
| Income Tax Expense
| 15.879 | 13.525 | -0.168 | 1.063 | 1.195 | -0.692 | 2.06 | -7.624 | -5.247 | -1.69 | 20.424 | 91.584 | -34.909 | 11.243 | 9.652 | 6.411 | -5.94 | 0 | 0 | 0 | -4.257 | 4.018 | 11.523 | 0 | 0 | 19 | -0.3 | -0.1 | 0 |
| Net Income
| -535.977 | -703.488 | -418.78 | -554.128 | -715.075 | -361.918 | -50.688 | -267.265 | -220.03 | -135.789 | -111.985 | -121.287 | -2.318 | -32.177 | -25.159 | -23.953 | -27.168 | -31.073 | -16.676 | -24.778 | -14.617 | -29.359 | -26.925 | -9.24 | -8.3 | -26.7 | -3.6 | -2.1 | -2.6 |
| Net Income Ratio
| -0.431 | -0.754 | -0.597 | -1.026 | -1.878 | -1.202 | -0.328 | -49.302 | -175.603 | -13.917 | -7.876 | -3.249 | -0.049 | -1.094 | -1.431 | -1.127 | -2.473 | -269.518 | -3.486 | -57.561 | -15.071 | -35.086 | -38.132 | -7.122 | -83 | -133.5 | -36 | -21 | -26 |
| EPS
| -5.8 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.2 | -3.39 | -3.31 | -5.14 | -0.11 | -1.74 | -1.62 | -2.07 | -3.02 | -3.54 | -2.24 | -4.13 | -2.94 | -6.86 | -7.21 | -2.96 | -3.71 | -13.57 | -2.14 | -1.5 | -2.17 |
| EPS Diluted
| -5.8 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.2 | -3.39 | -3.31 | -5.14 | -0.11 | -1.74 | -1.62 | -2.07 | -3.02 | -3.54 | -2.24 | -4.13 | -2.94 | -6.86 | -7.21 | -2.96 | -3.71 | -13.57 | -2.14 | -1.5 | -2.17 |
| EBITDA
| -267.824 | -473.535 | -412.118 | -529.276 | -469.424 | -342.763 | -238.731 | -266.73 | -220.184 | -131.01 | -68.257 | 63.76 | -68.949 | -7.969 | -4.93 | -9.317 | -36.05 | -30.893 | -15.519 | -23.156 | -21.155 | -19.529 | -2.323 | -9.825 | -7.9 | 11.5 | -3.8 | -1.9 | -2.1 |
| EBITDA Ratio
| -0.215 | -0.508 | -0.587 | -0.98 | -1.233 | -1.139 | -1.544 | -49.203 | -175.725 | -13.427 | -4.8 | 1.708 | -1.467 | -0.271 | -0.28 | -0.438 | -3.282 | -267.954 | -3.244 | -53.793 | -21.812 | -23.339 | -3.29 | -7.573 | -79 | 57.5 | -38 | -19 | -21 |